In vitro study on the effects of bradykinin potentiating factor and angiotensin II analogue on degradation and conversion of angiotensin I and II in plasma
- 17 May 1974
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 52 (3) , 287-292
- https://doi.org/10.1016/0009-8981(74)90112-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- REDUCTION OF PRESSOR EFFECTS OF ANGIOTENSIN I IN MAN BY SYNTHETIC NONAPEPTIDE (B.P.P.9a OR SQ 20,881) WHICH INHIBITS CONVERTING ENZYMEThe Lancet, 1973
- A New, Long-Lasting Competitive Inhibitor of AngiotensinScience, 1972
- Synthesis of some analogs of angiotensin II as specific antagonists of the parent hormoneJournal of Medicinal Chemistry, 1972
- Bradykinin potentiating peptide PCA-Lys-Trp-Ala-ProBiochemical Pharmacology, 1971
- Bradykinin-potentiating peptides from the venom of Agkistrodon halys. Isolation of five bradykinin potentiators and the amino acid sequences of two of them, potentiators B and CBiochemistry, 1971
- Activity of Various Fractions of Bradykinin Potentiating Factor against Angiotensin I Converting EnzymeNature, 1970
- Application of a Radioimmunoassay for Angiotensin I to the Physiologic Measurements of Plasma Renin Activity in Normal Human Subjects1Journal of Clinical Endocrinology & Metabolism, 1969
- Metabolism of the Angiotensins in Isolated Perfused TissuesNature, 1969